Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1731652171;52172;52173 chr2:178609364;178609363;178609362chr2:179474091;179474090;179474089
N2AB1567547248;47249;47250 chr2:178609364;178609363;178609362chr2:179474091;179474090;179474089
N2A1474844467;44468;44469 chr2:178609364;178609363;178609362chr2:179474091;179474090;179474089
N2B825124976;24977;24978 chr2:178609364;178609363;178609362chr2:179474091;179474090;179474089
Novex-1837625351;25352;25353 chr2:178609364;178609363;178609362chr2:179474091;179474090;179474089
Novex-2844325552;25553;25554 chr2:178609364;178609363;178609362chr2:179474091;179474090;179474089
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Ig-112
  • Domain position: 66
  • Structural Position: 98
  • Q(SASA): 0.0996
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/R rs368529230 -1.531 0.949 N 0.761 0.42 None gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.9E-06 0
L/R rs368529230 -1.531 0.949 N 0.761 0.42 None gnomAD-4.0.0 1.59456E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86384E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.286 likely_benign 0.2877 benign -1.31 Destabilizing 0.415 N 0.589 neutral None None None None N
L/C 0.5451 ambiguous 0.587 pathogenic -0.955 Destabilizing 0.996 D 0.671 neutral None None None None N
L/D 0.6809 likely_pathogenic 0.6571 pathogenic -0.682 Destabilizing 0.961 D 0.773 deleterious None None None None N
L/E 0.3835 ambiguous 0.3546 ambiguous -0.649 Destabilizing 0.961 D 0.753 deleterious None None None None N
L/F 0.1578 likely_benign 0.1675 benign -0.771 Destabilizing 0.923 D 0.691 prob.neutral None None None None N
L/G 0.5781 likely_pathogenic 0.5602 ambiguous -1.618 Destabilizing 0.961 D 0.731 prob.delet. None None None None N
L/H 0.319 likely_benign 0.3214 benign -0.59 Destabilizing 0.996 D 0.763 deleterious None None None None N
L/I 0.101 likely_benign 0.1179 benign -0.538 Destabilizing 0.197 N 0.571 neutral None None None None N
L/K 0.3484 ambiguous 0.3124 benign -0.882 Destabilizing 0.961 D 0.719 prob.delet. None None None None N
L/M 0.1346 likely_benign 0.1515 benign -0.642 Destabilizing 0.901 D 0.679 prob.neutral N 0.505963369 None None N
L/N 0.4477 ambiguous 0.4214 ambiguous -0.905 Destabilizing 0.987 D 0.796 deleterious None None None None N
L/P 0.1873 likely_benign 0.1605 benign -0.765 Destabilizing 0.003 N 0.518 neutral N 0.450014086 None None N
L/Q 0.2215 likely_benign 0.22 benign -0.99 Destabilizing 0.983 D 0.764 deleterious N 0.478305588 None None N
L/R 0.3096 likely_benign 0.2918 benign -0.339 Destabilizing 0.949 D 0.761 deleterious N 0.478305588 None None N
L/S 0.3355 likely_benign 0.3331 benign -1.496 Destabilizing 0.775 D 0.712 prob.delet. None None None None N
L/T 0.2536 likely_benign 0.2614 benign -1.336 Destabilizing 0.775 D 0.631 neutral None None None None N
L/V 0.1107 likely_benign 0.1298 benign -0.765 Destabilizing 0.008 N 0.318 neutral N 0.47754512 None None N
L/W 0.304 likely_benign 0.3206 benign -0.833 Destabilizing 0.996 D 0.755 deleterious None None None None N
L/Y 0.3313 likely_benign 0.3405 ambiguous -0.603 Destabilizing 0.961 D 0.7 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.